Sphaera Pharma to Present at the 31st Annual J.P. Morgan Healthcare Conference

Corporate Overview to be presented on Wednesday, January 9th at 11 AM Pacific Time at the 31st Annual Conference in San Francisco, California

JPMorgan Healthcare Conference 2013

SAN FRANCISCO--()--Sphaera Pharma today announced it will present at the 31st Annual JP Morgan Healthcare Conference in San Francisco. Sphaera’s President and Chief Executive Officer, Sundeep Dugar, Ph.D., will provide an overview of the company and its scientific programs on Wednesday, January 9, 2013 at 11 AM in the Emerging Markets- Asia Track.

About Sphaera Pharma

Sphaera Pharma is an integrated drug discovery and development organization led by pharma and biotech professionals. Headquartered in Singapore, with subsidiaries in U.S. and India, Sphaera aims to bridge innovation, resources and expertise in a collaborative model, that can harness the potential of emerging science by coupling it with translational experience and expertise to develop therapies cost effectively. Sphaera is discovering and developing a balanced portfolio of discovery projects and clinical programs that will potentially address important diseases in the areas of: oncology, metabolic disorders, pain and infectious disease. Additionally, Sphaera has developed a proprietary platform technology that can be applied to an array of drugs for repurposing, reprofiling, repositioning or rescuing. For additional information, please visit http://www.sphaerapharma.com.

Contacts

Sphaera Pharma
Justin T. Brown, 919-886-5423
justin.b@sphaerapharma.com
or
Abhinav Dhandia, +91 124 4187510
abhinav.d@sphaerapharma.com

Release Summary

Sphaera Pharma to present corporate overview at 2013 JP Morgan Healthcare Conference

Sharing

Contacts

Sphaera Pharma
Justin T. Brown, 919-886-5423
justin.b@sphaerapharma.com
or
Abhinav Dhandia, +91 124 4187510
abhinav.d@sphaerapharma.com